HuGE Literature Finder
Records 1-30
|
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases.
Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
|
Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.
Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
|
Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients.
Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
|
Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces.
Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
|
The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients.
International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
|
Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort.
BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
|
SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Archives of pathology & laboratory medicine 2021 Jan 145 (1): 90-98. Nambirajan Aruna, Singh Varsha, Bhardwaj Nishu, Mittal Saurabh, Kumar Sunil, Jain Deepa |
|
Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China.
Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
|
The landscape of kinase domain duplication in Chinese lung cancer patients.
Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
|
Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases.
The International journal of biological markers 2020 Oct 1724600820967015. Hu Mingming, Zhang Tongmei, Yang Yuan, Che Nanying, Li Jie, Liu Zichen, Li Baol |
|
EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.
Cancer reports (Hoboken, N.J.) 2020 Sep e1288. Tarigopula Anil, Ramasubban Gayathri, Chandrashekar Vani, Govindasami Perumal, Chandran Chit |
|
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing.
Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
|
A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients.
World journal of surgical oncology 2020 Jul 18 (1): 172. Zhang Xilin, Jiang Yan, Yu Huanming, Xia Hui, Wang Xia |
|
Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution.
Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
|
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Cancer 2020 May . Mack Philip C, Banks Kimberly C, Espenschied Carin R, Burich Rebekah A, Zill Oliver A, Lee Christine E, Riess Jonathan W, Mortimer Stefanie A, Talasaz AmirAli, Lanman Richard B, Gandara David |
|
Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population.
Scientific reports 2020 Feb 10 (1): 2707. Dang Anh-Thu Huynh, Tran Vu-Uyen, Tran Thanh-Truong, Thi Pham Hong-Anh, Le Dinh-Thong, Nguyen Lam, Nguyen Ngoc-Vu, Thi Nguyen Thai-Hoa, Nguyen Chu Van, Le Ha Thu, Thi Nguyen Mai-Lan, Le Vu Thuong, Nguyen Phuc Huu, Vo Binh Thanh, Thi Dao Hong-Thuy, Nguyen Luan Thanh, Van Nguyen Thien-Chi, Bui Quynh-Tram Nguyen, Nguyen Long Hung, Nguyen Nguyen Huu, Thi Nguyen Quynh-Tho, Le Truong Xuan, Do Thanh-Thuy Thi, Dinh Kiet Truong, Do Han Ngoc, Phan Minh-Duy, Nguyen Hoai-Nghia, Tran Le Son, Giang H |
|
Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Clinical lung cancer 2020 Feb . Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh |
|
Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study.
Journal of occupational and environmental medicine 2020 Jan Publish Ahead of Print . Yilmaz Senay, Demirci Nilgun Yilmaz, Metintas Selma, Zamani Adil, Karadag Mehmet, Guçlu Ozge A, Kabalak Pinar Akin, Yilmaz Ul |
|
Molecular profiling in lung cancer associated with cystic airspaces.
Acta clinica Belgica 2019 Oct 1-4. Snoeckx Annemiek, Reyntiens Pieter, Pauwels Patrick, Van Schil Paul E, Parizel Paul M, Van Meerbeeck Jan |
|
ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib.
BMC cancer 2019 Aug 19 (1): 769. Xu Shuguang, Wang Wenxian, Xu Chunwei, Li Xingliang, Ye Junhui, Zhu Youcai, Ge Ti |
|
The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) 2019 Jul 136 15-22. Lee Youngjoo, Jeon Jae Hyun, Goh Sung-Ho, Roh Hanseong, Yun Ji-Young, Kwon Nak-Jung, Choi Jin Ho, Yang Hee Chul, Kim Moon Soo, Lee Jong Mog, Lee Geon Kook, Han Ji-Yo |
|
Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.
Cancer science 2019 Apr . Sakai Kazuko, Ohira Tatsuo, Matsubayashi Jun, Yoneshige Azusa, Ito Akihiko, Mitsudomi Tetsuya, Nagao Toshitaka, Iwamatsu Emi, Katayama Jin, Ikeda Norihiko, Nishio Kazu |
|
Unique profiles of targetable genomic alterations and prognosis in young Chinese patients with lung adenocarcinoma.
Pathology, research and practice 2019 Apr . Chen Lijuan, Hu Xiufeng, Wu Huijuan, Liu Jie, Mu Xiaoqian, Wu Hongbo, Zhao Yanq |
|
[A Single Center, Retrospective Analysis of Prognosis in Non-small Cell Lung Cancer Patients with Peritoneal Carcinomatosis].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 Mar 22 (3): 143-150. Cao Baoshan, Liu Yan'e, Yin Wencheng, Li Qian, Liang |
|
Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
The oncologist 2019 Mar . Wen Shiwang, Dai Lei, Wang Lei, Wang Wenjian, Wu Duoguang, Wang Kefeng, He Zhanghai, Wang Aodi, Chen Hui, Zhang Peng, Dong Xiaowei, Dong Yu-An, Wang Kai, Yao Ming, Wang Mingh |
|
Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
Diagnostic pathology 2019 Feb 14 (1): 18. Grosse Alexandra, Grosse Claudia, Rechsteiner Markus, Soltermann Al |
|
Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology.
Diagnostic cytopathology 2019 Feb . Tanaka Ryota, Sakamoto Norihiko, Suzuki Hitomi, Tachibana Keisei, Ohtsuka Kouki, Kishimoto Koji, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
|
Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
|
Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas.
JCO precision oncology 2019 3 . Shen Ronglai, Martin Axel, Ni Ai, Hellmann Matthew, Arbour Kathryn C, Jordan Emmet, Arora Arshi, Ptashkin Ryan, Zehir Ahmet, Kris Mark G, Rudin Charles M, Berger Michael F, Solit David B, Seshan Venkatraman E, Arcila Maria, Ladanyi Marc, Riely Gregory |
|
Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.
PloS one 2019 14 (8): e0220691. Grosse Claudia, Soltermann Alex, Rechsteiner Markus, Grosse Alexand |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 16, 2021
- Content source: